Medicine & Life Sciences
Acute Myeloid Leukemia
100%
Leukemia
38%
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
36%
Cytarabine
32%
Myelodysplastic Syndromes
30%
Cyclophosphamide
25%
Bone Marrow
23%
Protein-Tyrosine Kinases
22%
Survival
19%
Therapeutics
16%
Acute Promyelocytic Leukemia
16%
alvocidib
15%
Neoplasms
15%
Graft vs Host Disease
14%
Transplantation
14%
1-(2-(1H-benzo(d)imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyanophenyl)urea
14%
lestaurtinib
13%
Sorafenib
12%
Bone Marrow Transplantation
12%
Cytogenetics
12%
Granulocyte-Macrophage Colony-Stimulating Factor
12%
Mutation
12%
Transplants
11%
Mitoxantrone
11%
Hematologic Neoplasms
11%
Homologous Transplantation
11%
Recurrence
11%
Leukemia, Myeloid, Chronic Phase
11%
Imatinib Mesylate
10%
Stem Cells
10%
Precursor Cell Lymphoblastic Leukemia-Lymphoma
9%
Philadelphia Chromosome
9%
Azacitidine
8%
Dasatinib
8%
Myeloid Cells
8%
Drug Therapy
8%
Arsenic Trioxide
7%
bryostatin 1
7%
Poly(ADP-ribose) Polymerase Inhibitors
7%
Apoptosis
7%
Progression-Free Survival
7%
Tissue Donors
7%
tipifarnib
7%
Clofarabine
7%
venetoclax
7%
In Vitro Techniques
7%
Haploidentical Transplantation
6%
Lymphocytes
6%
Methylation
6%
Checkpoint Kinase 1
6%